Blog
Archive
September 10, 2026
The UK National Commission on AI in Healthcare: What Its Recommendations Mean for AI Device Developers
September 10, 2026
ARPA-H ADVOCATE: The First Bid for FDA-Authorized Autonomous Clinical AI and What It Means for Developers
September 8, 2026
Governing Neuro-AI: What the EGE's Infrastructure Approach Means for Neurotech and AI Device Developers
August 28, 2026
AI in Mammography Screening: What a New Meta-Analysis of FDA-Cleared and CE-Marked Systems Shows
August 28, 2026
FDA Updates Its Human Factors Guidance: What Changed and What It Means for Device Developers
August 28, 2026
The FDA at 120: What 120 Years of Regulatory History Means for SaMD, AI, and XR Developers
August 28, 2026
The EU AI Act's New Timeline: What the Digital Omnibus Means for AI-Enabled Medical Devices
August 24, 2026
NSF's State and Regional AI Infrastructure Hubs: What They Mean for Medtech AI Developers
July 16, 2026
EN 18286 Passes the Formal Vote: What the First EU AI Act QMS Standard Means for AI/ML Device Makers
July 16, 2026
Validating Medical Device Cybersecurity Through Penetration Testing: What MDIC's New Best Practices Mean for Developers
July 16, 2026
Validating AI Segmentation Without a Gold Standard: A New FDA Method and What It Means for Developers
July 16, 2026
FDA Finalizes Human Factors Content Guidance for Marketing Submissions: What It Means and Why It Matters
May 12, 2025
Designing Your Software Medical Device (SaMD) Verification and Validation Plan, Protocol, and Report
May 12, 2025
How to create a Threat Model and Vulnerability Assessment to comply with FDA cybersecurity expectations.
July 1, 2024
Leveraging Computational Modeling for Medical Device Premarket Submissions: A Comprehensive Guide
June 26, 2024
FDA Guidance on Digital Health Devices For Treating Psychiatric Disorders during COVID-19
June 25, 2024
FDA Greenlights Revolutionary Skin Cancer Detection Device and the Regulatory Implications for Future AI/ML-enabled devices
June 25, 2024
